Closely monitor patients for signs of thromboembolic events, including deep vein thrombosis (DVT) and pulmonary embolism (PE), especially within the first two weeks post-surgery. Assess for symptoms such as leg pain, swelling, shortness of breath, and chest pain. Regularly check vital signs, paying particular attention to blood pressure and heart rate.
Perform regular neurological assessments, focusing on changes in mental status, speech, vision, or motor function, to detect potential central nervous system side effects. Document any changes and report them immediately to the attending physician.
Monitor renal function through regular blood tests, assessing creatinine levels and urine output. Adjust the tranexamic acid dosage based on renal function and according to the product’s prescribing information.
Observe for signs of allergic reactions, including rash, itching, hives, and angioedema. Patients should be instructed to report any such symptoms promptly. If a severe allergic reaction occurs, immediately discontinue tranexamic acid and administer appropriate treatment.
Regularly assess the surgical site for bleeding and signs of infection. Document findings and take appropriate measures as needed. The frequency of monitoring depends on the individual patient and surgical procedure. Consult the surgeon’s post-operative instructions.
Maintain adequate hydration. This helps to reduce the risk of renal complications and promotes overall patient well-being.
Carefully review patient history for contraindications before administering tranexamic acid. This includes a thorough assessment of bleeding disorders, active seizures, and history of thromboembolic events. Any concerns should be addressed with the attending physician.
